Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Важность гликемического контроля у пациентов с коморбидной патологией
________________________________________________
Vasiltseva O.Ya., Vorozhczova I.N. Glycemic control importance in patients with comorbid pathology. Consilium Medicum. 2018; 20 (10): 96–100. DOI: 10.26442/2075-1753_2018.10.96-100
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: сахарный диабет, гликемия, факторы риска, прогноз, самоконтроль.
________________________________________________
Key words: diabetes mellitus, glycemia, risk factors, prognosis, self-control.
3. Дедов И.И., Мельниченко Г.А. Эндокринология. Национальное руководство. Под ред. И.И.Дедова, Г.А.Мельниченко. М.: ГЭОТАР-Медиа, 2013. / Dedov I.I., Melnichenko G.A. Endokrinologiya. Nacional'noe rukovodstvo. Pod red. I.I.Dedova, G.A.Melnichenko. M.: GEHOTAR-Media, 2013. [in Russian]
4. Ogurtsova K, da Rocha Fernandes JD, Huang Y et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40–50. DOI: 10.1016/j.diabres.2017.03.024
5. Mayer-Davis EJ, Lawrence JM, Dabelea D et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med 2017; 376 (15): 1419–29. DOI: 10.1056/NEJMoa1610187
6. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. VI пересмотр. М., 2017. / Diagnostika i korrekciya narushenij lipidnogo obmena s cel'yu profilaktiki i lecheniya ateroskleroza. Rossijskie rekomendacii. VI peresmotr. M., 2017. [in Russian]
7. Артериальная гипертония у взрослых. Клинические рекомендации. М., 2016. / Arterial'naya gipertoniya u vzroslyh. Klinicheskie rekomendacii. M., 2016. [in Russian]
8. Стабильная ишемическая болезнь сердца. Клинические рекомендации. М., 2016. / Stabil'naya ishemicheskaya bolezn' serdca. Klinicheskie rekomendacii. M., 2016. [in Russian]
9. Yudkin JS, Richter B, Gale EAM. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 2010; 53 (10): 2079–85. DOI: 10.1007/s00125-010-1864-z
10. Кочергина И.И. Контроль гликемии у больных сахарным диабетом и кардиальной патологией. Consilium Medicum. 2017; 1 (19): 56–60. / Kochergina I.I. Glycemic control in patients with diabetes mellitus and cardiac pathology. Consilium Medicum. 2017; 19 (1): 56–60. [in Russian]
11. Kengne AP, Patel A, Marre M et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J of Cardiovasc Prevent Rehab 2011; 18: 393–8. DOI: 10.1177/1741826710394270.
12. Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomed Res 2010; 21 (2): 147–50.
13. Bartnik M, Ryden L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25 (21): 1880–90.
14. Duckworth WC, McCarren M, Abraira С. Glucose Control and Cardiovascular Complications: The VA Diabetes Tria. Diabetes Care 2001; 24 (5): 942–5.
15. Bouche JL, Hurrell DJ. Cardiovascular Disease and Diabetes. Diabet spectrum 2008; 21 (3): 54–5.
16. Левит Ш., Филиппов Ю.И., Горелышев А.С. Сахарный диабет 2-го типа: время изменить концепцию. Сахарный диабет. 2013; 1: 91–102. / Levit SH., Filippov Yu.I., Gorelyshev A.S. Saharnyj diabet 2-go tipa: vremya izmenit' koncepciyu. Saharnyj diabet. 2013; 1: 91–102. [in Russian]
17. Асфандиярова Н.С. Смертность при сахарном диабете 2-го типа. Сахарный диабет. 2015; 18 (4): 12–21. / Asfandiyarova N.S. Smertnost' pri saharnom diabete 2-go tipa. Saharnyj diabet. 2015; 18 (4): 12–21. [in Russian]
18. Bai J, Ding X, Du X et al. Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis. Thrombosis Research 2015; 135 (1): 90–5. DOI: 10.1016/j.thromres.2014.11.003
19. Dentali F, Ageno W, Pomero F. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost 2016; 115 (2): 399–405. DOI: 10.1160/TH15-02-0172
20. Powers WJ, Derdeyn CP, Biller J et al. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the AHA/ASA. Stroke 2015; 46 (10): 3020–35. DOI: 10.1161/STR.0000000000000074
21. Meschia JF, Bushnell C, Boden-Albala B et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the AHA/ASA. Stroke 2014; 45 (12): 3754–832. DOI: 10.1161/STR.0000000000000046
22. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC. Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Heart J 2016; 37: 2893–962. DOI: 10.1093/eurheartj/ehw210
23. Konstantinides SV, Torbicki A, Agnelli G et al. Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the ESC Endorsed by the ERS. Eur Heart J 2014; 35 (43): 3033–73. DOI: 10.1093/eurheartj/ehu393
24. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений (ВТЭО). Флебология. 2015; 4 (2): 1–52. / Rossijskie klinicheskie rekomendacii po diagnostike, lecheniyu i profilaktike venoznyh tromboehmbolicheskih oslozhnenij (VTEHO). Flebologiya. 2015; 4 (2): 1–52. [in Russian]
25. Васильцева О.Я., Крестинин А.В., Щипунов Е.Ф. и др. Регистр пациентов с заболеваниями сердечно-сосудистой системы: свидетельство о регистрации электронного ресурса №17631; заявл. 28.11.2009; опубл. 01.12.2011. Навигатор в мире науки и образования. 2011; 11 (30): 28. / Vasiltseva O.Ya., Krestinin A.V., Shchipunov E.F. i dr. Registr pacientov s zabolevaniyami serdechno-sosudistoj sistemy: svidetel'stvo o registracii ehlektronnogo resursa №17631; zayavl. 28.11.2009; opubl. 01.12.2011. Navigator v mire nauki i obrazovaniya. 2011; 11 (30): 28. [in Russian]
26. Васильцева О.Я., Ворожцова И.Н., Карпов Р.С. Госпитальная тромбоэмболия правых камер сердца. Кардиология. 2013; 6: 46–50. / Vasiltseva O.Ya., Vorozhcova I.N., Karpov R.S. Gospital'naya tromboehmboliya pravyh kamer serdca. Kardiologiya. 2013; 6: 46–50. [in Russian]
27. Buerger С, Plock N, Dehghanyar P et al. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob Agents Chemother 2006; 50: 2455–63.
28. Chin-Hong PV. Infections in patients with diabetes mellitus: importance of early recognition, treatment and prevention. Adv Stud Med 2006; 6 (2): 71–81.
29. Асфандиярова Н.С. Смертность при сахарном диабете 2-го типа. Сахарный диабет. 2015; 18 (4): 12–21. / Asfandiyarova N.S. Smertnost' pri saharnom diabete 2-go tipa. Saharnyj diabet. 2015; 18 (4): 12–21. [in Russian]
30. Кукушкин Г.В., Старостина Е.Г. Инфекции у больных сахарным диабетом. РМЖ. 2016; 20: 1327–33. / Kukushkin G.V., Starostina E.G. Infekcii u bol'nyh saharnym diabetom. RMZh. 2016; 20: 1327–33. [in Russian]
31. Johnston KC, Hall CE, Kissela et al. Glucose regulation in acute stroke patients (GRASP) trial a randomized pilot trial. Stroke 2009; 40: 12: 3804–09. DOI: 10.1161/STROKEAHA.109.561498
32. Федотова А.И., Катков В.А., Максимов И.В., Марков В.А. Опыт применения протокола инфузионной инсулинотерапии в остром периоде инфаркта миокарда у пациентов с сахарным диабетом. СМЖ. 2011; 26 (4) 2: 132–5. / Fedotova A.I., Katkov V.A., Maksimov I.V., Markov V.A. Opyt primeneniya protokola infuzionnoj insulinoterapii v ostrom periode infarkta miokarda u pacientov s saharnym diabetom. SMZH. 2011; 26 (4) 2: 132–5. [in Russian]
33. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Рос. кардиол. журн. 2018; 6: 7–122. Kardiovaskulyarnaya profilaktika 2017. Rossijskie nacional'nye rekomendacii. Ros. kardiol. zhurn. 2018; 6: 7–122. DOI: org/10.15829/1560-4071-2018-6-7-122. / [in Russian]
34. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355 (4): 773–8.
35. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 10: 2426–32.
36. Дедов И.И., Шестакова М.В. Эпидемиология сахарного диабета и микрососудистых осложнений. Сахарный диабет. 2010; 3: 17–22. / Dedov I.I., Shestakova M.V. Ehpidemiologiya saharnogo diabeta i mikrososudistyh oslozhnenij. Saharnyj diabet. 2010; 3: 17–22. [in Russian]
37. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359 (15): 1577–89. DOI: 10.1056/NEJMoa0806
38. Стронгин Л.Г., Григорян И.Г., Густов А.В., Беляева Н.Г. Инсулинотерапия сахарного диабета 2-го типа в остром периоде инсульта: значение метода введения инсулина. Проблемы эндокрин. 2014; 60 (5): 4–8. DOI: 10.14341/probl20146054-8 / Strongin L.G., Grigoryan I.G., Gustov A.V., Belyaeva N.G. Insulinoterapiya saharnogo diabeta 2-go tipa v ostrom periode insul'ta: znachenie metoda vvedeniya insulina. Problemy ehndokrin. 2014; 60 (5): 4–8. DOI: 10.14341/probl20146054-8 [in Russian]
39. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction the CREATE-ECLA Randomized Controlled Trial. JAMA 2005; 293 (4): 437–46.
40. NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360 (13): 1283–97.
41. Bruno A, Kent TA, Coull BM et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008; 39 (2): 384–9. DOI: 10.1161/strokeaha.107.493544
42. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction the CREATE-ECLA Randomized Controlled Trial. JAMA 2005; 293 (4): 437–46.
43. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300: 933–44.
44. Лаптев Д.Н., Шмушкович И.А. Аритмогенный эффект гипогликемии. Сахарный диабет. 2012; 1: 25–30. / Laptev D.N., Shmushkovich I.A. Aritmogennyj ehffekt gipoglikemii. Saharnyj diabet. 2012; 1: 25–30. [in Russian]
45. Gerstein HC, Miller ME, Byington RP et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358 (24): 2545–59.
46. Patel A, MacMahon S, Chalmers J et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358 (24): 2560–72.
47. Duckworth W, Abraira C, Moritz T et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360 (2): 129–39.
48. Дедов И.И., Шестакова М.В., Аметов А.С. и др. Инициация и интенсификация сахароснижающей терапии у больных сахарным диабетом 2-го типа: обновление консенсуса совета экспертов Российской ассоциации эндокринологов (2015 г.). Сахарный диабет. 2015; 1: 5–23. / Dedov I.I., Shestakova M.V., Ametov A.S. i dr. Iniciaciya i intensifikaciya saharosnizhayushchej terapii u bol'nyh saharnym diabetom 2-go tipa: obnovlenie konsensusa soveta ehkspertov Rossijskoj associacii ehndokrinologov (2015 g.). Saharnyj diabet. 2015; 1: 5–23. [in Russian]
49. Garber AJ, Abrahamson MJ, Barzilay JI et al. AACE and ACE Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan – 2015. Endocr Pract 2015; 21 (12): 1403–14. DOI: 10.4158/EP151063.CS
50. Tian F, Chen Y, Liu H et al. Assessment of characteristics of neointimal hyperplasia after drug-eluting stent implantation in patients with diabetes mellitus: an optical coherence tomography analysis. Cardiology 2014; 128 (1): 34–40.
51. Богданов А.Н., Добрынина И.Ю., Добрынин Ю.В. Ишемический инсульт при сахарном диабете 2-го типа. Наука XXI века: вопросы, гипотезы, ответы. 2014; 4 : 43–52. / Bogdanov A.N., Dobrynina I.Yu., Dobrynin Yu.V. Ishemicheskij insul't pri saharnom diabete 2-go tipa. Nauka XXI veka: voprosy, gipotezy, otvety. 2014; 4 : 43–52. [in Russian]
52. Рунова Г.Е. Самоконтроль гликемии при сахарном диабете: медицинские и психологические аспекты. Consilium Medicum. 2016; 18 (5): 98–102. / Runova G.E. Self-control glycemia in diabetes: medical and psychological aspects. Consilium Medicum. 2016; 18 (5): 98–102. [in Russian]
53. Clar C, Barnard K, Cummins E et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12). DOI: 10.3310/hta14120
54. Freckmann G, Baumstark A, Jendrike N et al. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther 2010; 12 (3): 221–31.
55. International Standard EN ISO 15197: 2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013; р. 46.
56. Dunne N, Viggiani MT, Pardo S et al. Accuracy Evaluation of CONTOUR® PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6 (3): 377–88.
57. Аметов А.С., Черникова Н.А. Гликемический контроль у пациентов с сахарным диабетом 2-го типа. Consilium Medicum. 2016; 18 (4): 24–7. / Ametov A.S., Chernikova N.A. Glycemic control in patients with type 2 diabetes. Consilium Medicum. 2016; 18 (4): 24–7. [in Russian]
________________________________________________
1. Algoritmy specializirovannoj medicinskoj pomoshchi bol'nym saharnym diabetom. Vyp. 8. Pod red. I.I.Dedova, M.V.Shestakovoj, A.Yu.Majorova. M., 2017. [in Russian]
2. Shestakova M.V., Suhareva O.Yu. Diagnostika i vybor metoda lecheniya saharnogo diabeta 2-go tipa. Klin. farmakologiya i terapiya. 2018; 2: 3–9. [in Russian]
3. Dedov I.I., Melnichenko G.A. Endokrinologiya. Nacional'noe rukovodstvo. Pod red. I.I.Dedova, G.A.Melnichenko. M.: GEHOTAR-Media, 2013. [in Russian]
4. Ogurtsova K, da Rocha Fernandes JD, Huang Y et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40–50. DOI: 10.1016/j.diabres.2017.03.024
5. Mayer-Davis EJ, Lawrence JM, Dabelea D et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med 2017; 376 (15): 1419–29. DOI: 10.1056/NEJMoa1610187
6. Diagnostika i korrekciya narushenij lipidnogo obmena s cel'yu profilaktiki i lecheniya ateroskleroza. Rossijskie rekomendacii. VI peresmotr. M., 2017. [in Russian]
7. Arterial'naya gipertoniya u vzroslyh. Klinicheskie rekomendacii. M., 2016. [in Russian]
8. Stabil'naya ishemicheskaya bolezn' serdca. Klinicheskie rekomendacii. M., 2016. [in Russian]
9. Yudkin JS, Richter B, Gale EAM. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 2010; 53 (10): 2079–85. DOI: 10.1007/s00125-010-1864-z
10. Kochergina I.I. Glycemic control in patients with diabetes mellitus and cardiac pathology. Consilium Medicum. 2017; 19 (1): 56–60. [in Russian]
11. Kengne AP, Patel A, Marre M et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J of Cardiovasc Prevent Rehab 2011; 18: 393–8. DOI: 10.1177/1741826710394270.
12. Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomed Res 2010; 21 (2): 147–50.
13. Bartnik M, Ryden L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25 (21): 1880–90.
14. Duckworth WC, McCarren M, Abraira С. Glucose Control and Cardiovascular Complications: The VA Diabetes Tria. Diabetes Care 2001; 24 (5): 942–5.
15. Bouche JL, Hurrell DJ. Cardiovascular Disease and Diabetes. Diabet spectrum 2008; 21 (3): 54–5.
16. Levit SH., Filippov Yu.I., Gorelyshev A.S. Saharnyj diabet 2-go tipa: vremya izmenit' koncepciyu. Saharnyj diabet. 2013; 1: 91–102. [in Russian]
17. Asfandiyarova N.S. Smertnost' pri saharnom diabete 2-go tipa. Saharnyj diabet. 2015; 18 (4): 12–21. [in Russian]
18. Bai J, Ding X, Du X et al. Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis. Thrombosis Research 2015; 135 (1): 90–5. DOI: 10.1016/j.thromres.2014.11.003
19. Dentali F, Ageno W, Pomero F. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost 2016; 115 (2): 399–405. DOI: 10.1160/TH15-02-0172
20. Powers WJ, Derdeyn CP, Biller J et al. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the AHA/ASA. Stroke 2015; 46 (10): 3020–35. DOI: 10.1161/STR.0000000000000074
21. Meschia JF, Bushnell C, Boden-Albala B et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the AHA/ASA. Stroke 2014; 45 (12): 3754–832. DOI: 10.1161/STR.0000000000000046
22. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC. Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Heart J 2016; 37: 2893–962. DOI: 10.1093/eurheartj/ehw210
23. Konstantinides SV, Torbicki A, Agnelli G et al. Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the ESC Endorsed by the ERS. Eur Heart J 2014; 35 (43): 3033–73. DOI: 10.1093/eurheartj/ehu393
24. Rossijskie klinicheskie rekomendacii po diagnostike, lecheniyu i profilaktike venoznyh tromboehmbolicheskih oslozhnenij (VTEHO). Flebologiya. 2015; 4 (2): 1–52. [in Russian]
25. Vasiltseva O.Ya., Krestinin A.V., Shchipunov E.F. i dr. Registr pacientov s zabolevaniyami serdechno-sosudistoj sistemy: svidetel'stvo o registracii ehlektronnogo resursa №17631; zayavl. 28.11.2009; opubl. 01.12.2011. Navigator v mire nauki i obrazovaniya. 2011; 11 (30): 28. [in Russian]
26. Vasiltseva O.Ya., Vorozhcova I.N., Karpov R.S. Gospital'naya tromboehmboliya pravyh kamer serdca. Kardiologiya. 2013; 6: 46–50. [in Russian]
27. Buerger С, Plock N, Dehghanyar P et al. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob Agents Chemother 2006; 50: 2455–63.
28. Chin-Hong PV. Infections in patients with diabetes mellitus: importance of early recognition, treatment and prevention. Adv Stud Med 2006; 6 (2): 71–81.
29. Asfandiyarova N.S. Smertnost' pri saharnom diabete 2-go tipa. Saharnyj diabet. 2015; 18 (4): 12–21. [in Russian]
30. Kukushkin G.V., Starostina E.G. Infekcii u bol'nyh saharnym diabetom. RMZh. 2016; 20: 1327–33. [in Russian]
31. Johnston KC, Hall CE, Kissela et al. Glucose regulation in acute stroke patients (GRASP) trial a randomized pilot trial. Stroke 2009; 40: 12: 3804–09. DOI: 10.1161/STROKEAHA.109.561498
32. Fedotova A.I., Katkov V.A., Maksimov I.V., Markov V.A. Opyt primeneniya protokola infuzionnoj insulinoterapii v ostrom periode infarkta miokarda u pacientov s saharnym diabetom. SMZH. 2011; 26 (4) 2: 132–5. [in Russian]
33. Kardiovaskulyarnaya profilaktika 2017. Rossijskie nacional'nye rekomendacii. Ros. kardiol. zhurn. 2018; 6: 7–122. DOI: org/10.15829/1560-4071-2018-6-7-122. / [in Russian]
34. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355 (4): 773–8.
35. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 10: 2426–32.
36. Dedov I.I., Shestakova M.V. Ehpidemiologiya saharnogo diabeta i mikrososudistyh oslozhnenij. Saharnyj diabet. 2010; 3: 17–22. [in Russian]
37. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359 (15): 1577–89. DOI: 10.1056/NEJMoa0806
38. Strongin L.G., Grigoryan I.G., Gustov A.V., Belyaeva N.G. Insulinoterapiya saharnogo diabeta 2-go tipa v ostrom periode insul'ta: znachenie metoda vvedeniya insulina. Problemy ehndokrin. 2014; 60 (5): 4–8. DOI: 10.14341/probl20146054-8 [in Russian]
39. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction the CREATE-ECLA Randomized Controlled Trial. JAMA 2005; 293 (4): 437–46.
40. NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360 (13): 1283–97.
41. Bruno A, Kent TA, Coull BM et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008; 39 (2): 384–9. DOI: 10.1161/strokeaha.107.493544
42. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction the CREATE-ECLA Randomized Controlled Trial. JAMA 2005; 293 (4): 437–46.
43. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300: 933–44.
44. Laptev D.N., Shmushkovich I.A. Aritmogennyj ehffekt gipoglikemii. Saharnyj diabet. 2012; 1: 25–30. [in Russian]
45. Gerstein HC, Miller ME, Byington RP et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358 (24): 2545–59.
46. Patel A, MacMahon S, Chalmers J et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358 (24): 2560–72.
47. Duckworth W, Abraira C, Moritz T et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360 (2): 129–39.
48. Dedov I.I., Shestakova M.V., Ametov A.S. i dr. Iniciaciya i intensifikaciya saharosnizhayushchej terapii u bol'nyh saharnym diabetom 2-go tipa: obnovlenie konsensusa soveta ehkspertov Rossijskoj associacii ehndokrinologov (2015 g.). Saharnyj diabet. 2015; 1: 5–23. [in Russian]
49. Garber AJ, Abrahamson MJ, Barzilay JI et al. AACE and ACE Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan – 2015. Endocr Pract 2015; 21 (12): 1403–14. DOI: 10.4158/EP151063.CS
50. Tian F, Chen Y, Liu H et al. Assessment of characteristics of neointimal hyperplasia after drug-eluting stent implantation in patients with diabetes mellitus: an optical coherence tomography analysis. Cardiology 2014; 128 (1): 34–40.
51. Bogdanov A.N., Dobrynina I.Yu., Dobrynin Yu.V. Ishemicheskij insul't pri saharnom diabete 2-go tipa. Nauka XXI veka: voprosy, gipotezy, otvety. 2014; 4 : 43–52. [in Russian]
52. Runova G.E. Self-control glycemia in diabetes: medical and psychological aspects. Consilium Medicum. 2016; 18 (5): 98–102. [in Russian]
53. Clar C, Barnard K, Cummins E et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12). DOI: 10.3310/hta14120
54. Freckmann G, Baumstark A, Jendrike N et al. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther 2010; 12 (3): 221–31.
55. International Standard EN ISO 15197: 2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013; р. 46.
56. Dunne N, Viggiani MT, Pardo S et al. Accuracy Evaluation of CONTOUR® PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6 (3): 377–88.
57. Ametov A.S., Chernikova N.A. Glycemic control in patients with type 2 diabetes. Consilium Medicum. 2016; 18 (4): 24–7. [in Russian]
1 ФГБНУ «Томский национальный исследовательский медицинский центр» Российской академии наук, Научно-исследовательский институт кардиологии. 634012, Россия, Томск, ул. Киевская, д. 111а;
*vasiltseva@cardio-tomsk.ru
________________________________________________
1 Tomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Cardiology. 634012, Russian Federation, Tomsk, ul. Kievskaya, d. 111a;
*vasiltseva@cardio-tomsk.ru